These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11829825)

  • 21. Alpha-1 adrenergic receptors in liver plasma membranes of cirrhotic patients with portal hypertension: a quantitative study.
    Zhang Y; Leng X; Zhu J; Peng J; Du R
    Chin Med J (Engl); 1998 Jun; 111(6):507-9. PubMed ID: 11245068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].
    Zhu J; Du R; Leng X
    Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):144-6. PubMed ID: 9387666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of venous derivations in hemorrhage caused by portal hypertension of cirrhotic origin (45 cases)].
    Lataste J; Robin B
    Presse Med (1893); 1968 Jan; 76(5):185-8. PubMed ID: 5300142
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pressure-adjusted arterialization of the liver with portacaval anastomosis in the treatment of portal hypertension in liver cirrhosis].
    Matzander U
    Bull Soc Int Chir; 1971; 30(5):483-9. PubMed ID: 5158261
    [No Abstract]   [Full Text] [Related]  

  • 26. [Remote results of portacaval shunts for portal hypertension caused by intra- and extrahepatic block].
    Leger L; Lenriot JP; Boccon-Gibod L; Lagneau P; Gillot C; Lemaigre G
    Bull Mem Soc Med Hop Paris; 1967 Nov 3-10; 118(12):1089-100. PubMed ID: 5586116
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of side-to-side mesocaval shunt, pericardial devascularization, and a combined procedure in cirrhotic rats].
    Zhang FX
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):151-4, 189. PubMed ID: 2379425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
    Gaudin C; Braillon A; Poo JL; Kleber G; Moreau R; Lebrec D
    Hepatology; 1991 May; 13(5):913-6. PubMed ID: 2029995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperkinetic portal hypertension. Arterioportal fistula: problems--case reports--review of the literature].
    Hirner A; Häring R; Bost H; Sörensen R
    Chirurg; 1978 May; 49(5):303-10. PubMed ID: 648268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined devascularization and proximal splenorenal shunt: is this a better option than either procedure alone?
    Xu CE; Zhang SG; Yu ZH; Li GX; Cao LL; Ruan CL; Li ZT
    J Hepatobiliary Pancreat Surg; 2004; 11(2):129-34. PubMed ID: 15127277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension].
    Leng X; Zhu J; Du R
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):330-2. PubMed ID: 11825402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiopathology of portal hypertension. Circulatory neophysiology after portacaval shunt.
    Leger L; Lenriot JP; Lemaigre G
    Major Probl Clin Surg; 1974; 14():165-95. PubMed ID: 4359433
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma glucagon concentration in cirrhosis is related to liver function but not to portal-systemic shunting, systemic vascular resistance, or urinary sodium excretion.
    Lewis FW; Adair O; Hossack KF; Everson GT; White JC; Rector WG
    J Lab Clin Med; 1991 Jan; 117(1):67-75. PubMed ID: 1987311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of phentolamine on portal pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Yin J
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):92-4. PubMed ID: 10374485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and experimental studies on elevated plasma level of insulin in cirrhotic patients with portal hypertension and portosystemic collateral circulation].
    Arakawa T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):468-81. PubMed ID: 6379413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between polymorphism of TaqI of ET-1 gene and cirrhotic portal hypertension].
    Lin JS; Cheng YQ; Liao JZ; Liang KH; Xiong P
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):463-6. PubMed ID: 12887757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patients with liver cirrhosis and portal hypertension: survival after decompressive shunt operation].
    Vanermen H; Lepoutre L; Fevery J; Daenen W; Suy R; De Groote J; Stalpaert G
    Tijdschr Gastroenterol; 1978; 21(6):417-30. PubMed ID: 756100
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diet in chronic portal encephalopathy in cirrhotic patients with a surgical portacaval anastomosis].
    Urdea L; Păunescu G
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1979 Feb; 27(2):31-5. PubMed ID: 106534
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilharzial portal fibrosis: an important cause of portal hypertension.
    Carruthers RH; Sinha P
    Ann R Coll Surg Engl; 1978 Jan; 60(1):49-52. PubMed ID: 626472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
    Chesta J; Generini G; Antezana C; Defilippi C
    Rev Med Chil; 1992 Sep; 120(9):998-1002. PubMed ID: 1340993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.